Compositions for Mesoderm derived ISL1+ Multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent CXCR4+CD56+ cells (C56Cs) and methods of use

Details for Australian Patent Application No. 2009274517 (hide)

Owner The University of Georgia Research Foundation, Inc.

Inventors Dalton, Stephen; Reynolds, David

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2009274517

PCT Pub. Number WO2010/011352

Priority 61/198,861 10.11.08 US; 61/137,058 25.07.08 US; 61/215,621 07.05.09 US

Filing date 27 July 2009

Wipo publication date 28 January 2010

International Classifications

C12N 5/0775 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Mesenchymal stem cells

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

Event Publications

17 February 2011 PCT application entered the National Phase

  PCT publication WO2010/011352 Priority application(s): WO2010/011352

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274543-Removable attachment for footwear

2009274512-Clip inhibitors and methods of modulating immune function